These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19118281)

  • 1. O-linked beta-N-acetylglucosamine: a new piece of the cardioprotection puzzle?
    Downey JM; Cohen MV
    Circ Res; 2009 Jan; 104(1):7-8. PubMed ID: 19118281
    [No Abstract]   [Full Text] [Related]  

  • 2. Unique hexosaminidase reduces metabolic survival signal and sensitizes cardiac myocytes to hypoxia/reoxygenation injury.
    Ngoh GA; Facundo HT; Hamid T; Dillmann W; Zachara NE; Jones SP
    Circ Res; 2009 Jan; 104(1):41-9. PubMed ID: 19023128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-GlcNAc signaling attenuates ER stress-induced cardiomyocyte death.
    Ngoh GA; Hamid T; Prabhu SD; Jones SP
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1711-9. PubMed ID: 19734355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sweet nature of cardioprotection.
    Zachara NE
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1324-6. PubMed ID: 17586610
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between protein O-linked glycosylation and insulin-stimulated glucose transport in rat skeletal muscle following calorie restriction or exposure to O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate.
    Arias EB; Cartee GD
    Acta Physiol Scand; 2005 Mar; 183(3):281-9. PubMed ID: 15743388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stressing the role of O-GlcNAc: linking cell survival to keratin modification.
    Rotty JD; Hart GW; Coulombe PA
    Nat Cell Biol; 2010 Sep; 12(9):847-9. PubMed ID: 20811358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-β precursor protein (APP).
    Jacobsen KT; Iverfeldt K
    Biochem Biophys Res Commun; 2011 Jan; 404(3):882-6. PubMed ID: 21182826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protective effects of PUGNAc on cardiac function after trauma-hemorrhage are mediated via increased protein O-GlcNAc levels.
    Zou L; Yang S; Hu S; Chaudry IH; Marchase RB; Chatham JC
    Shock; 2007 Apr; 27(4):402-8. PubMed ID: 17414423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of O-GlcNAcase by a gluco-configured nagstatin and a PUGNAc-imidazole hybrid inhibitor.
    Shanmugasundaram B; Debowski AW; Dennis RJ; Davies GJ; Vocadlo DJ; Vasella A
    Chem Commun (Camb); 2006 Nov; (42):4372-4. PubMed ID: 17057847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.
    Yokoe S; Asahi M; Takeda T; Otsu K; Taniguchi N; Miyoshi E; Suzuki K
    Glycobiology; 2010 Oct; 20(10):1217-26. PubMed ID: 20484118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells.
    Johnson B; Opimba M; Bernier J
    Biochim Biophys Acta; 2014 Jan; 1840(1):191-8. PubMed ID: 24035784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
    Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
    J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucosamine modulates TNF-α-induced ICAM-1 expression and function through O-linked and N-linked glycosylation in human retinal pigment epithelial cells.
    Chen CL; Liang CM; Chen YH; Tai MC; Lu DW; Chen JT
    Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2281-91. PubMed ID: 22427561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the O-linked β-N-acetylglucosamine in the cardioprotection induced by isoflurane.
    Hirose K; Tsutsumi YM; Tsutsumi R; Shono M; Katayama E; Kinoshita M; Tanaka K; Oshita S
    Anesthesiology; 2011 Nov; 115(5):955-62. PubMed ID: 21876430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes.
    Park SY; Ryu J; Lee W
    Exp Mol Med; 2005 Jun; 37(3):220-9. PubMed ID: 16000877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PUGNAc treatment leads to an unusual accumulation of free oligosaccharides in CHO cells.
    Mehdy A; Morelle W; Rosnoblet C; Legrand D; Lefebvre T; Duvet S; Foulquier F
    J Biochem; 2012 Apr; 151(4):439-46. PubMed ID: 22337894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intracellular fate of zonula occludens 2 is regulated by the phosphorylation of SR repeats and the phosphorylation/O-GlcNAcylation of S257.
    Quiros M; Alarcón L; Ponce A; Giannakouros T; González-Mariscal L
    Mol Biol Cell; 2013 Aug; 24(16):2528-43. PubMed ID: 23804652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synthesis and biological evaluation of some carbocyclic analogues of PUGNAc.
    Scaffidi A; Stubbs KA; Vocadlo DJ; Stick RV
    Carbohydr Res; 2008 Nov; 343(16):2744-53. PubMed ID: 18804755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged incubation in PUGNAc results in increased protein O-Linked glycosylation and insulin resistance in rat skeletal muscle.
    Arias EB; Kim J; Cartee GD
    Diabetes; 2004 Apr; 53(4):921-30. PubMed ID: 15047606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A.
    Onishi A; Miyamae M; Kaneda K; Kotani J; Figueredo VM
    Eur J Pharmacol; 2012 Jan; 675(1-3):40-6. PubMed ID: 22166375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.